J Korean Med Sci.  2009 Jan;24(Suppl 1):S215-S218. 10.3346/jkms.2009.24.S1.S215.

Relapsing Peritonitis Caused by Bordetella bronchiseptica in Continuous Ambulatory Peritoneal Dialysis Patient: A Case Report

• Won KB
• Ha GY
• Kim JS
• Kang HJ
• Tak WT
• Lee JH

• KMID: 1778165
• DOI: http://doi.org/10.3346/jkms.2009.24.S1.S215

Abstract

Bordetella (B) bronchiseptica is a common veterinary pathogen, but has rarely been implicated in human infections. Most patients with B. bronchiseptica infections are compromised clinically such as in patients with a malignancy, AIDS, malnutrition, or chronic renal failure. We experienced a case of relapsing peritonitis caused by B. bronchiseptica associated with continuous ambulatory peritoneal dialysis (CAPD). A 56-yr-old male, treated with CAPD due to end stage renal disease (ESRD), was admitted with complaints of abdominal pain and a turbid peritoneal dialysate. The culture of peritoneal dialysate identified B. bronchiseptica. The patient was treated with a combination of intraperitoneal antibiotics. There were two further episodes of relapsing peritonitis, although the organism was sensitive to the used antibiotics. Finally, the indwelling CAPD catheter was removed and the patient was started on hemodialysis. This is the first report of a B. bronchiseptica human infection in the Korean literature.

Keyword

Bordetella Bronchiseptica; Peritonitis; Peritoneal Dialysis, Continuous Ambulatory

MeSH Terms

Anti-Bacterial Agents/pharmacology/therapeutic use
Bordetella Infections/*diagnosis/microbiology
Bordetella bronchiseptica/*metabolism
Fibrosis
Humans
Kidney Failure/microbiology
Male
Middle Aged
Peritoneal Dialysis, Continuous Ambulatory/*methods
Peritoneum/pathology
Peritonitis/*microbiology
Recurrence

Figure

• 

  Fig. 1 Gram-stained smear of peritoneal dialysate showing scattered gram-negative coccobacilli (arrows) among neutrophils.

• 

  Fig. 2 Sheep blood agar plate showing 1-2 mm sized, raised, grayish-white colonies after 48 hr incubation at 37℃C, 5%-CO2.

• 

  Fig. 3 Gram-stained smear of colony on BAP after 48 hr incubation at 37℃C showing gram negative coccobacili.

Reference

1. Woolfrey BF, Moody JA. Human infection associated with Bordetella bronchiseptica. Clin Microbiol Rev. 1991. 4:243–255.

2. Papasian CJ, Downs NJ, Talley RL, Romberger DJ, Hodges GR. Bordetella bronchiseptica bronchitis. J Clin Microbiol. 1987. 25:575–577.

3. Byrd LH, Anama L, Gutkin M, Chmel H. Bordetella bronchiseptica peritonitis associated with continuous ambulatory peritoneal dialysis. J Clin Microbiol. 1981. 14:232–233.

4. Amador C, Chiner E, Calpe JL, Ortiz de la Table V, Martinez C, Pasquau F. Pneumonia due to Bordetella bronchiseptica in a patient with AIDS. Rev Infect Dis. 1991. 13:771–772.

5. Ghosh HK, Tranter J. Bordetella bronchicanis (bronchiseptica) infection in man: review and a case report. J Clin Pathol. 1979. 32:546–548.

6. Fenton P. Laboratory diagnosis of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. J Clin Pathol. 1982. 35:1181–1184.

7. Rubin J, Rogers WA, Taylor HM, Everett FD, Prowant BF, Fruto LV, Nolph KD. Peritonitis during continuous ambulatory peritoneal dialysis. Ann Intern Med. 1980. 92:7–13.

8. Chew CG, Clarkson AR, Faull RJ. Relapsing CAPD peritonitis with rapid peritoneal sclerosis due to Haemophilus influenzae. Nephrol Dial Transplant. 1997. 12:821–822.

9. Vargemezis V, Thodis E. Prevention and management of peritonitis and exit-site infection in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2001. 16:Suppl 6. 106–108.

10. Pickett MJ, Greenwood JR. Identification of oxidase-positive, glucose-negative, motile species of nonfermentative bacilli. J Clin Microbiol. 1986. 23:920–923.

11. Burns EH Jr, Norman JM, Hatcher MD, Bemis DA. Fimbriae and determination of host species specificity of Bordetella bronchiseptica. J Clin Microbiol. 1993. 31:1838–1844.

12. Le Blay K, Gueirard P, Guiso N, Chaby R. Antigenic polymorphism of the lipopolysaccharides from human and animal isolates of Bordetella bronchiseptica. Microbiology. 1997. 143:1433–1441.

13. Gokal R, Ramos JM, Francis DM, Ferner RE, Goodship TH, Proud G, Bint AJ, Ward MK, Kerr DN. Peritonitis in continuous ambulatory peritoneal dialysis laboratory and clinical studies. Lancet. 1982. 2:1388–1391.

14. Buggy BP, Brosius FC 3rd, Bogin RM, Koller CA, Schaberg DR. Bordetella bronchiseptica pneumonia in a patient with chronic lymphocytic leukemia. South Med J. 1987. 80:1187–1189.

15. Stoll DB, Murphey SA, Ballas SK. Bordetella bronchiseptica infection in stage IV Hodgkin's disease. Postgrad Med J. 1981. 57:723–724.

16. Meis JF, van Griethuijsen AJ, Muytjens HL. Bordetella bronchiseptica bronchitis in an immunosuppressed patient. Eur J Clin Microbiol Infect Dis. 1990. 9:366–367.

17. Mesnard R, Guiso N, Michelet C, Sire JM, Pouedras P, Donnio PY, Avril JL. Isolation of Bordetella bronchiseptica from a patient with AIDS. Eur J Clin Microbiol Infect Dis. 1993. 12:304–306.

18. Bauwens JE, Spach DH, Schacker TW, Mustafa MM, Bowden RA. Bordetella bronchiseptica pneumonia and bacteremia following bone marrow transplantation. J Clin Microbiol. 1992. 30:2474–2475.

19. Gueirard P, Weber C, Le Coustumier A, Guiso N. Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host. J Clin Microbiol. 1995. 33:2002–2006.

20. Mortensen JE, Brumbach A, Shryock TR. Antimicrobial susceptibility of Bordetella avium and Bordetella bronchiseptica isolates. Antimicrob Agents Chemother. 1989. 33:771–772.